Here are Thursday's biggest analyst calls: Nvidia, Apple, Broadcom, Netflix, Oracle, Microsoft, CrowdStrike & more

Wall Street call activity was broadly constructive, led by multiple upgrades and reiterated bullish ratings on Broadcom, Nvidia, Microsoft, Oracle, CrowdStrike, Alphabet, and UnitedHealth. Key calls highlighted AI demand, strong earnings/FCF trends, and favorable outlooks for defense, logistics, and healthcare names, while Broadcom also saw a downgrade on Google insourcing concerns. The most notable target moves included Broadcom to $502, CrowdStrike to $690, Oracle to $330, and Medtronic to a Buy with a $90 target.

Analysis

The clearest read-through is that AI infrastructure demand is still outrunning supply-chain concentration risk, but the winners are shifting from the obvious compute layer to the bottleneck layers: networking, power, and financed capacity. That is constructive for NVDA, CRDO, LITE, ORCL, and the AI-capex beneficiaries adjacent to hyperscale buildouts, while the Broadcom downgrade is a warning that single-customer dependency is becoming a valuation discount rather than a premium. In other words, the market is rewarding diversified picks-and-shovels exposure and punishing anything that can be disintermediated by in-house silicon or alternate vendors.

On software, MSFT and CRWD look like the cleaner medium-term expressions because the demand signal is broadening from experimentation to deployment. The second-order effect is that AI adoption is finally showing up in workflow budgets and security spend, which tends to lengthen revenue visibility and compress the probability of a near-term multiple reset. AAPL remains the odd one out: if WWDC disappoints on AI monetization, it risks underperforming even in a tape that is otherwise tolerant of premium duration names.

Defense, logistics, and healthcare are the quieter macro beneficiaries. RTX and UNH have asymmetric setups because both are levered to multi-quarter fundamentals rather than headline-driven re-rating, while FDX Freight and KRT are more tactical beneficiaries of pricing/margin recovery than of top-line growth alone. The main risk is that some of these upgrades are arriving after partial recovery, so the trade is less about chasing and more about owning names where consensus underestimates the slope of earnings revision momentum over the next 2-3 quarters.

The most interesting contrarian setup is AVGO vs. GOOGL: if Alphabet keeps insourcing, Broadcom’s terminal multiple may compress even if near-term results stay strong, while GOOGL’s capex intensity likely stays elevated longer than the market expects. Likewise, the bullish calls on WULF/CIFR and VG imply the market is starting to price AI power scarcity and geopolitics as durable margin supports; that trade can work, but it is highly sensitive to financing conditions and any moderation in hyperscaler demand.

Key Decisions for Investors

• Rotate from AVGO into a basket of NVDA/CRDO/LITE on a 1-3 month horizon; prefer a relative-value long NVDA vs short AVGO if you want AI upside without the single-customer insourcing overhang.
• Add to MSFT and CRWD on any post-headline weakness; use a 3-6 month view as AI monetization and security budget conversion should drive estimate revisions, with downside best defined by slowing adoption signals rather than valuation alone.
• Express a WWDC hedge via short AAPL or AAPL call spreads into the event; the risk/reward favors a limited-premium expression because the market appears to be pricing a high bar for AI differentiation.
• Long RTX vs short a lower-quality defense peer or the broader industrials basket over 2-4 quarters; the thesis is free-cash-flow durability plus budget support, with limited sensitivity to near-term macro noise.
• Speculative long WULF/CIFR only as a paired trade against a funding-sensitive small-cap basket; the upside is rapid AI-revenue optionality, but position sizing should reflect financing and execution risk over the next 6-12 months.